e.g. Tata motors, Reliance MF, 500570

Emcure Pharmaceuticals Ltd. - Research Center

544210 EMCURE Group (B) BSE data
 
Back to Company Page
Results:

Quarterly results in brief

(Rs crore)
Dec' 24 Sep' 24 Jun' 24
Sales 1,028.81 1,104.63 970.29
Operating profit 124.42 152.16 115.19
Interest 19.93 31.40 37.57
Gross profit 123.90 175.69 110.13
EPS (Rs) 2.65 4.60 2.23

Quarterly  results in details

Dec' 24 Sep' 24 Jun' 24
Other income 19.41 54.93 32.51
Stock adjustment -47.69 -53.30 -8.42
Raw material 350.91 325.99 266.07
Power and fuel - - -
Employee expenses 196.01 191.12 195.09
Excise - - -
Admin and selling expenses - - -
Research and development expenses - - -
Expenses capitalised - - -
Other expenses 405.17 488.67 402.36
Provisions made - - -
Depreciation 56.65 56.34 55.08
Taxation 17.05 32.44 14.60
Net profit / loss 50.20 86.92 40.45
Extra ordinary item - - -
Prior year adjustments - - -
Equity capital 189.43 189.10 181.15
Equity dividend rate - - -
Agg.of non-prom. shares (Lacs) - - -
Agg.of non promotoholding (%) - - -
OPM (%) 12.09 13.77 11.87
GPM (%) 11.82 15.15 10.98
NPM (%) 4.79 7.50 4.03
Close
Add Emcure Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Emcure Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close